Cyber Security and Resilience (Network and Information Systems) Bill: HL Bill 32 of 2026–27

The Cyber Security and Resilience (Network and Information Systems) Bill is a government bill intended to strengthen the cyber security of organisations in the UK that provide essential services, such as healthcare, drinking water and energy. It would amend the Network and Information Systems (NIS) Regulations 2018 to include additional sectors and update incident reporting duties. It would also confer powers on the secretary of state to amend the legislation and issue directions to organisations when necessary for national security. The bill is scheduled for its second reading in the House of Lords on 14 July 2026.

Cyber Security and Resilience (Network and Information Systems) Bill: HL Bill 32 of 2026–27

Child poverty: Government policy

The government established a taskforce in July 2024 to develop a strategy to reduce child poverty in the UK. Published in December 2025, the strategy included a combination of previously implemented and new policies. While charities, think tanks and other groups generally welcomed the strategy, particularly the removal of the two-child universal credit limit and extension of free school meals, some argued for further reforms to the social security system.

Child poverty: Government policy

Law on the regulation of fertility treatment

The Human Fertilisation and Embryology Act 1990 regulates in vitro fertilisation (IVF) and human embryo research in the UK. Recently, there have been calls for reform to reflect changes in societal attitudes and scientific developments since the act was last updated in 2008. The government has said it is considering recommendations made by the Human Fertilisation and Embryology Authority, the sector’s independent regulator.

Law on the regulation of fertility treatment

  • In Focus

    AI regulation in the UK: Debate on the need for cross-sector legislation

    The UK does not have AI-specific legislation or regulators. The government previously planned to introduce an AI bill to “ensure the safe development and use of AI models” but has since opted for a more targeted approach. Supporters of cross-sector legislation argue it is required to mitigate a broad range of current and future AI risks while critics claim this approach may stifle innovation through excessive regulatory burdens.

  • In Focus

    Cyber security and the UK government

    Cyber security is becoming an increasingly salient issue as society becomes more dependent on digital services and the capabilities of malicious actors evolve. The government is a significant target for cyber attacks, particularly those aiming to disrupt public services or conduct espionage. This briefing provides an introduction to cyber security and recent plans to strengthen government cyber security.

  • In Focus

    Financial Services Regulation Committee report on the secondary international competitiveness and growth objective

    The House of Lords Financial Services Regulation Committee held an inquiry into the progress made by financial services regulators in strengthening the international competitiveness of the UK economy. The committee’s report, published in June 2025, highlighted cultural and regulatory barriers undermining this objective. The government and regulators stated that the committee’s recommendations align closely with planned and ongoing reforms. On 11 March 2026 the House of Lords is scheduled to debate the Financial Services Regulation Committee report ‘Growing pains: Clarity and culture change required’, published on 13 June 2025.

  • In Focus

    Potential future risks from autonomous AI systems

    Some experts argue that future autonomous AI systems may be able to evade human oversight and control. The likelihood and potential impacts of such “loss of control” incidents are debated as the trajectory of future AI advancement is uncertain. To address this risk, the UK has adopted non-statutory principles to guide responsible development and use but currently lacks AI-specific regulations or legislation.

  • In Focus

    Including societal and economic benefits in vaccine health technology assessments

    To gain approval for use in the NHS, vaccines must undergo health technology assessments that are based primarily on clinical outcomes and costs to the healthcare sector. Some argue that this approach undervalues vaccines and that broader socioeconomic benefits, such as gains in productivity and educational attainment, should be considered in all assessments. Critics of this proposal point to a range of ethical, practical and methodological challenges.

  • In Focus

    AI in the NHS

    Artificial intelligence (AI) arguably has the potential to deliver considerable cost and time savings in healthcare by automating some administrative and clinical tasks. The government plans to expand the use of AI in the NHS but public sentiment is divided. This briefing explores the main concerns and outlines key questions for regulating this technology.

  • In Focus

    Financial provision on divorce and dissolution: Law Commission financial remedies scoping report

    The Law Commission has published a review of the law governing financial remedies on divorce and dissolution in England and Wales. They concluded that the current law lacks certainty and accessibility and that there was need for reform. The report outlined potential models of reform and key policy choices that the government would need to make under each model.

  • Research Briefing

    Space Industry (Indemnities) Bill: HL Bill 120 of 2024–25

    The Space Industry (Indemnities) Bill is a private member’s bill, supported by the government, that would amend the Space Industry Act 2018 to require all spaceflight operator licences to specify a limit on a licence holder's liability for damage or loss. This is intended to encourage investment in the UK space industry by ensuring that operators are not subject to unlimited liability.

  • In Focus

    World’s first personalised DNA editing treatment

    US scientists have used a breakthrough therapy to edit an infant’s DNA and correct a life-threatening mutation. Preliminary results suggest the approach may have been successful, potentially paving the way for addressing a range of genetic diseases. This briefing investigates this cutting-edge technology and considers the key challenges of regulatory approval and high costs.